Literature DB >> 23011871

Molecular patterns in the evolution of serrated lesion of the colorectum.

Timo Gaiser1, Sandra Meinhardt, Daniela Hirsch, Jonathan Keith Killian, Jochen Gaedcke, Peter Jo, Immaculada Ponsa, Rosa Miró, Josef Rüschoff, Gerhard Seitz, Yue Hu, Jordi Camps, Thomas Ried.   

Abstract

Colorectal cancer (CRC) mostly develops from a variety of polyps following mainly three different molecular pathways: chromosomal instability (CIN), microsatellite instability (MSI) and CpG island methylation (CIMP). Polyps are classified histologically as conventional adenomas, hyperplastic polyps, sessile serrated adenomas/polyps (SSA/P) and traditional serrated adenomas (TSA). However, the association of these polyps with the different types of CRCs and the underlying genetic and epigenetic aberrations has yet to be resolved. In order to address this question we analyzed 140 tumors and 20 matched mucosae by array comparative genomic hybridization, by sequence analysis of the oncogenes BRAF, KRAS, PI3K3CA and by methylation arrays. MSI was tested indirectly by immunohistochemistry (IHC) and a loss of MLH1, MSH2, MSH6 or PMS2 was assigned as high microsatellite instability (MSI-H), while low microsatellite instability (MSI-L) was defined as MGMT IHC negativity only. CIN was detected in 78% of all MSI-H CRCs, most commonly as a gain of chromosome 8. Methylation data analyses allowed classification of samples into four groups and detected similar methylation profiles in SSA/P and MSI-H CRC. TSA also revealed aberrant methylation pattern, but clustered more heterogeneously and closer to microsatellite stable (MSS) CRCs. SSA/P, TSA and MSI-H CRCs had the highest degree of promotor methylation (CIMP pathway). Chromosomal instability, in contrast to the established doctrine, is a common phenomenon in MSI CRCs, yet to a lower extent and at later stages than in MSS CRCs. Methylation analyses suggest that SSA/P are precursors for MSI-H CRCs and follow the CIMP pathway.
Copyright © 2012 UICC.

Entities:  

Mesh:

Year:  2012        PMID: 23011871      PMCID: PMC7542204          DOI: 10.1002/ijc.27869

Source DB:  PubMed          Journal:  Int J Cancer        ISSN: 0020-7136            Impact factor:   7.396


  48 in total

Review 1.  Colorectal serrated adenocarcinoma.

Authors:  M J Mäkinen
Journal:  Histopathology       Date:  2007-01       Impact factor: 5.087

2.  CpG island methylator phenotype underlies sporadic microsatellite instability and is tightly associated with BRAF mutation in colorectal cancer.

Authors:  Daniel J Weisenberger; Kimberly D Siegmund; Mihaela Campan; Joanne Young; Tiffany I Long; Mark A Faasse; Gyeong Hoon Kang; Martin Widschwendter; Deborah Weener; Daniel Buchanan; Hoey Koh; Lisa Simms; Melissa Barker; Barbara Leggett; Joan Levine; Myungjin Kim; Amy J French; Stephen N Thibodeau; Jeremy Jass; Robert Haile; Peter W Laird
Journal:  Nat Genet       Date:  2006-06-25       Impact factor: 38.330

3.  CpG island methylation in sporadic colorectal cancers and its relationship to microsatellite instability.

Authors:  Nicholas Hawkins; Mark Norrie; Kay Cheong; Elisa Mokany; Su-Lyn Ku; Alan Meagher; Terence O'Connor; Robyn Ward
Journal:  Gastroenterology       Date:  2002-05       Impact factor: 22.682

Review 4.  The epigenomics of cancer.

Authors:  Peter A Jones; Stephen B Baylin
Journal:  Cell       Date:  2007-02-23       Impact factor: 41.582

5.  Genome and transcriptome profiles of CD133-positive colorectal cancer cells.

Authors:  Timo Gaiser; Jordi Camps; Sandra Meinhardt; Danny Wangsa; Quang Tri Nguyen; Sudhir Varma; Claudia Dittfeld; Leoni A Kunz-Schughart; Ralf Kemmerling; Maria R Becker; Kerstin Heselmeyer-Haddad; Thomas Ried
Journal:  Am J Pathol       Date:  2011-04       Impact factor: 4.307

6.  BRAF and KRAS Mutations in hyperplastic polyps and serrated adenomas of the colorectum: relationship to histology and CpG island methylation status.

Authors:  Shi Yang; Francis A Farraye; Charline Mack; Oksana Posnik; Michael J O'Brien
Journal:  Am J Surg Pathol       Date:  2004-11       Impact factor: 6.394

7.  CpG island methylator phenotype associates with low-degree chromosomal abnormalities in colorectal cancer.

Authors:  Yu-Wei Cheng; Hanna Pincas; Manny D Bacolod; Gunter Schemmann; Sarah F Giardina; Jianmin Huang; Sandra Barral; Kamran Idrees; Sajid A Khan; Zhaoshi Zeng; Shoshana Rosenberg; Daniel A Notterman; Jurg Ott; Philip Paty; Francis Barany
Journal:  Clin Cancer Res       Date:  2008-10-01       Impact factor: 12.531

8.  Mapping of genetic abnormalities of primary tumours from metastatic CRC by high-resolution SNP arrays.

Authors:  José María Sayagués; Celia Fontanillo; María del Mar Abad; María González-González; María Eugenia Sarasquete; Maria del Carmen Chillon; Eva Garcia; Oscar Bengoechea; Emilio Fonseca; Marcos Gonzalez-Diaz; Javier De las Rivas; Luís Muñoz-Bellvis; Alberto Orfao
Journal:  PLoS One       Date:  2010-10-29       Impact factor: 3.240

Review 9.  Epigenetic changes in colorectal cancer.

Authors:  Yutaka Kondo; Jean-Pierre J Issa
Journal:  Cancer Metastasis Rev       Date:  2004 Jan-Jun       Impact factor: 9.264

10.  Tumor karyotype predicts clinical outcome in colorectal cancer patients.

Authors:  Georgia Bardi; Claus Fenger; Bertil Johansson; Felix Mitelman; Sverre Heim
Journal:  J Clin Oncol       Date:  2004-07-01       Impact factor: 44.544

View more
  19 in total

1.  Comprehensive DNA Methylation and Mutation Analyses Reveal a Methylation Signature in Colorectal Sessile Serrated Adenomas.

Authors:  Árpád V Patai; Barbara Kinga Barták; Bálint Péterfia; Tamás Micsik; Réka Horváth; Csaba Sumánszki; Zoltán Péter; Árpád Patai; Gábor Valcz; Alexandra Kalmár; Kinga Tóth; Tibor Krenács; Zsolt Tulassay; Béla Molnár
Journal:  Pathol Oncol Res       Date:  2016-11-29       Impact factor: 3.201

2.  IGF2 differentially methylated region hypomethylation in relation to pathological and molecular features of serrated lesions.

Authors:  Takafumi Naito; Katsuhiko Nosho; Miki Ito; Hisayoshi Igarashi; Kei Mitsuhashi; Shinji Yoshii; Hironori Aoki; Masafumi Nomura; Yasutaka Sukawa; Eiichiro Yamamoto; Yasushi Adachi; Hiroaki Takahashi; Masao Hosokawa; Masahiro Fujita; Toshinao Takenouchi; Reo Maruyama; Hiromu Suzuki; Yoshifumi Baba; Kohzoh Imai; Hiroyuki Yamamoto; Shuji Ogino; Yasuhisa Shinomura
Journal:  World J Gastroenterol       Date:  2014-08-07       Impact factor: 5.742

Review 3.  Evolving notions on immune response in colorectal cancer and their implications for biomarker development.

Authors:  Fabio Grizzi; Gianluca Basso; Elena Monica Borroni; Tommaso Cavalleri; Paolo Bianchi; Sanja Stifter; Maurizio Chiriva-Internati; Alberto Malesci; Luigi Laghi
Journal:  Inflamm Res       Date:  2018-01-10       Impact factor: 4.575

4.  Differences in DNA methylation signatures reveal multiple pathways of progression from adenoma to colorectal cancer.

Authors:  Yanxin Luo; Chao-Jen Wong; Andrew M Kaz; Slavomir Dzieciatkowski; Kelly T Carter; Shelli M Morris; Jianping Wang; Joseph E Willis; Karen W Makar; Cornelia M Ulrich; James D Lutterbaugh; Martha J Shrubsole; Wei Zheng; Sanford D Markowitz; William M Grady
Journal:  Gastroenterology       Date:  2014-04-30       Impact factor: 22.682

Review 5.  [Colorectal tumor evolution in inflammatory bowel disease : Dynamics of genomic alterations and potential molecular markers to predict malignant progression].

Authors:  D Hirsch
Journal:  Pathologe       Date:  2019-12       Impact factor: 1.011

6.  Colorectal cancer: Is the new era of colorectal cancer classification finally here?

Authors:  Iris D Nagtegaal; J Han J M van Krieken
Journal:  Nat Rev Gastroenterol Hepatol       Date:  2013-05-21       Impact factor: 46.802

7.  Dynamics of Genome Alterations in Crohn's Disease-Associated Colorectal Carcinogenesis.

Authors:  Karoline Horisberger; Thomas Ried; Timo Gaiser; Daniela Hirsch; Darawalee Wangsa; Yuelin J Zhu; Yue Hu; Daniel C Edelman; Paul S Meltzer; Kerstin Heselmeyer-Haddad; Claudia Ott; Peter Kienle; Christian Galata
Journal:  Clin Cancer Res       Date:  2018-07-02       Impact factor: 12.531

8.  Single-cell genetic analysis of clonal dynamics in colorectal adenomas indicates CDX2 gain as a predictor of recurrence.

Authors:  David Fiedler; Kerstin Heselmeyer-Haddad; Daniela Hirsch; Leanora S Hernandez; Irianna Torres; Darawalee Wangsa; Yue Hu; Luis Zapata; Josef Rueschoff; Sebastian Belle; Thomas Ried; Timo Gaiser
Journal:  Int J Cancer       Date:  2018-12-11       Impact factor: 7.396

9.  Cap assisted colonoscopy for the detection of serrated polyps: a post-hoc analysis.

Authors:  Fadi Rzouq; Neil Gupta; Sachin Wani; Prateek Sharma; Ajay Bansal; Amit Rastogi
Journal:  BMC Gastroenterol       Date:  2015-02-05       Impact factor: 3.067

10.  B-RAF mutation and accumulated gene methylation in aberrant crypt foci (ACF), sessile serrated adenoma/polyp (SSA/P) and cancer in SSA/P.

Authors:  A Inoue; K Okamoto; Y Fujino; T Nakagawa; N Muguruma; K Sannomiya; Y Mitsui; T Takaoka; S Kitamura; H Miyamoto; T Okahisa; T Fujimori; I Imoto; T Takayama
Journal:  Br J Cancer       Date:  2014-10-14       Impact factor: 7.640

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.